GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eris Lifesciences Ltd (BOM:540596) » Definitions » Construction In Progress

Eris Lifesciences (BOM:540596) Construction In Progress : ₹0 Mil (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Eris Lifesciences Construction In Progress?

Eris Lifesciences's quarterly construction in progress increased from Jun. 2023 (₹0 Mil) to Sep. 2023 (₹577 Mil) but then declined from Sep. 2023 (₹577 Mil) to Dec. 2023 (₹0 Mil).

Eris Lifesciences's annual construction in progress increased from Mar. 2021 (₹0 Mil) to Mar. 2022 (₹240 Mil) but then declined from Mar. 2022 (₹240 Mil) to Mar. 2023 (₹214 Mil).


Eris Lifesciences Construction In Progress Historical Data

The historical data trend for Eris Lifesciences's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eris Lifesciences Construction In Progress Chart

Eris Lifesciences Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.48 - - 240.04 213.78

Eris Lifesciences Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 213.78 - 577.18 -

Eris Lifesciences Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


Eris Lifesciences (BOM:540596) Business Description

Traded in Other Exchanges
Address
Ramdas Road, Plot No. 142/2, Shivarth Ambit, Off SBR, Near Swati Bungalows, Bodakdev, Ahmedabad, GJ, IND, 380054
Eris Lifesciences Ltd is an India-based company engaged in the manufacturing and sale of branded pharmaceutical formulations. It focuses on Lifestyle therapies such as Diabetes Care, Cardiac Care, Nutrition, Central Nervous System, and others. The company operates in a single segment that is pharmaceuticals. Some of its brands include Glimisave, Cyblex, Eritel, Atorsave and Crevast.

Eris Lifesciences (BOM:540596) Headlines

No Headlines